Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers
Analytical Biochemistry · 2024
DOI: 10.1016/j.ab.2024.115480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2024. Verfasst von Maria Barra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University, Houston, TX, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Human papillomavirus 18. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Prevent Cancer Foundation.
Abstract (Originalsprache)
Isothermal nucleic acid amplification methods have many advantages for use at the point of care. However, there is a lack of multiplexed isothermal amplification tests to detect multiple targets in a single reaction, which would be valuable for many diseases, such as infection with high-risk human papillomavirus (hrHPV). In this study, we developed a multiplexed loop-mediated isothermal amplification (LAMP) reaction to detect the three most common hrHPV types that cause cervical cancer (HPV16, HPV18, and HPV45) and a cellular control for sample adequacy. First, we characterized the assay limit of detection (LOD) in a real-time reaction with fluorescence readout; after 30 min of amplification the LOD was 100, 10, and 10 copies/reaction of HPV16, HPV18, and HPV45, respectively, and 0.1 ng/reaction of human genomic DNA (gDNA). Next, we implemented the assay on lateral flow strips, and the LOD was maintained for HPV16 and HPV18, but increased to 100 copies/reaction for HPV45 and to 1 ng/reaction for gDNA. Lastly, we used the LAMP test to evaluate total nucleic acid extracted from 38 clinical samples; compared to qPCR, the LAMP test had 89% sensitivity and 95% specificity. When integrated with sample preparation, this multiplexed LAMP assay could be useful for point-of-care testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Rice University, Houston, TX, USA.
- Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Pediatrics Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
- Basic Health International, San Salvador, El Salvador.
- Department of Bioengineering, Rice University, Houston, TX, USA. Electronic address: rkortum@rice.edu.
Förderung
- NCI NIH HHS
- National Cancer Institute
- Prevent Cancer Foundation
Zitieren
APA
Barra, M., Chang, M., Salcedo, M. P., Schmeler, K., Scheurer, M., Maza, M., Lopez, L., Alfaro, K., & Richards-Kortum, R. (2024). Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2024.115480
Vancouver
Barra M, Chang M, Salcedo MP, Schmeler K, Scheurer M, Maza M, et al. Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers. Analytical Biochemistry. 2024. doi:10.1016/j.ab.2024.115480
BibTeX
@article{Barra2024,
author = {Barra, Maria and Chang, Megan and Salcedo, Mila P and Schmeler, Kathleen and Scheurer, Michael and Maza, Mauricio and Lopez, Leticia and Alfaro, Karla and Richards-Kortum, Rebecca},
title = {Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers},
journal = {Analytical Biochemistry},
year = {2024},
doi = {10.1016/j.ab.2024.115480}
}
EUVIMED